FDA scientists applied a four-part statutory test under 21 CFR 216.23(c): physical and chemical characterization, historical compounding use, evidence of effectiveness, and safety
Following the action of MCAD and SCAD the resulting enoyl-CoAs are substrates for the enoyl-CoA hydratase encoded by the ECHS1 (enoyl-CoA hydratase, short chain 1
Cardiovascular health People with existing cardiovascular conditions should approach any new compound cautiously
At this point, there is no peer-reviewed evidence confirming its safety or effectiveness in humans
More serious B12 deficiencies have the potential to impair heart and neurological function, leading to a wide range of serious symptoms, including but not limited to tinnitus, severe joint pain, memory problems, depression, anxiety, poor muscle function, ataxia and changes in reflexes